Reteta vs RevMaxx (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

Two small scribes that treat coding as part of the job rather than as a downstream problem, generating structured notes with diagnosis and procedure codes attached. For a small practice without a dedicated coder that is a real proposition, because the gap between a finished note and a submitted claim is where independent practices lose money. The two are close enough on paper that the honest advice is to pilot both on your own specialty and see which needs less correction. What neither publishes is the thing that should worry a buyer: no accuracy figure, no add to delete ratio, and no audit result showing the suggested codes were justified. A tool that raises your coding level looks identical to a tool that raises your audit exposure until someone checks, and the vendor will not be the party answering for it.

The case for Reteta
  • It arrived from a longer development cycle with venture backing behind it, which for a small vendor is a signal about how long the product is likely to be maintained.
  • The scribe and coding combination is the same shape, so the comparison comes down to fit and support rather than to capability on paper.
  • For a practice evaluating both, the deciding factor is usually which one handles your specialty's documentation without constant correction.
The case for RevMaxx
  • Coding is handled alongside documentation in one pass, generating structured notes with the diagnosis and procedure codes attached rather than leaving the coding to a second system.
  • For a small practice without a coder, having the codes arrive with the note is the difference between billing this week and billing next month.
  • A single product covering both removes the reconciliation step where documentation and codes drift apart.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Reteta and RevMaxx are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Reteta RevMaxx
Primary category Ambient Scribes Ambient Scribes
Founded 2024 Not recorded
Headquarters Cranbury, New Jersey Tampa, Florida, United States
Website reteta.com revmaxx.co
Attribute Matrix

Side by Side

Select any grade to read the note behind it.

Axis
R
Reteta
R
RevMaxx
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each vendor in one paragraph

Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.

Reteta

Ambient scribe and coding platform launched October 2024 by Visionet Ventures out of Cranbury, New Jersey, after roughly two years of development and backed by $2 million in seed funding. The company is small, in the range of one to ten people.

Source: AI Health Index, August 2026

RevMaxx

RevMaxx is an ambient scribe aimed at practices that want documentation and coding handled together, generating structured SOAP notes with ICD-10, CPT and HCC codes and surfacing RAF score calculations from the conditions captured. Its workflow is described with an explicit gate: the note is generated, the clinician reviews, edits and signs, and only then does it update the chart.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

How are Reteta and RevMaxx priced and sold?

For Reteta, the routes in are a demo request and marketplace listings, neither of which exposes a rate.

With RevMaxx, a free trial at no cost with five notes; Basic at $39 per provider per month for 200 notes or 3,000 minutes of recorded conversation, whichever comes first; Standard at $79 for 400 notes or 7,500 minutes; Premier at $199 for unlimited notes and unlimited minutes. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.

How do Reteta and RevMaxx handle patient data?

In Reteta's case, one derived attribute stands apart. The after-visit summary generation reads the patient's language preference and infers their health literacy level in order to adapt what it produces.

For RevMaxx, the first qualifier is in a retention claim. The vendor states that clinical information is never stored or shared without your permission. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.

Disclosure

Both vendors market improved coding capture alongside documentation, which is the coding gradient in its most direct form: a product that suggests more codes raises revenue whether or not the codes are justified, and neither publishes an audit result, an add to delete ratio or an accuracy figure for its suggestions. Neither publishes a security attestation, retention schedule or subprocessor list, and neither has a published study, third party rating or named deployment. For any practice adopting either, the question to settle first is who is accountable if a payer audit finds the generated codes unsupported, because the answer is not the vendor.